Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Federal Trade Commission
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
US Army
Colorcon
Cantor Fitzgerald

Generated: December 9, 2018

DrugPatentWatch Database Preview

Drug Price Trends for AMITRIPTYLINE HCL

« Back to Dashboard

Drug Price Trends for AMITRIPTYLINE HCL

Average Pharmacy Cost for AMITRIPTYLINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AMITRIPTYLINE HCL 50 MG TAB 70710-1227-00 0.31617 EA 2018-11-28
AMITRIPTYLINE HCL 10 MG TAB 70710-1225-00 0.08273 EA 2018-11-28
AMITRIPTYLINE HCL 150 MG TAB 70710-1230-01 1.11111 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for AMITRIPTYLINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
AMITRIPTYLINE HCL 100MG TAB 10X10 Mylan Institutional, Inc. 51079-0563-20 100UD 76.39 0.76390 EA 2017-12-28 - 2022-09-29 FSS
AMITRIPTYLINE HCL 25MG TAB 10X10 Mylan Institutional, Inc. 51079-0107-20 100UD 19.68 0.19680 EA 2017-11-15 - 2022-09-29 FSS
AMITRIPTYLINE HCL 25MG TAB 10X10 Mylan Institutional, Inc. 51079-0107-20 100UD 19.02 0.19020 EA 2017-12-28 - 2022-09-29 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
UBS
Accenture
Johnson and Johnson
Harvard Business School
Express Scripts
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.